100 filings
Page 2 of 5
8-K
6f5orwh9 gdd
17 Aug 20
Sanofi to acquire Principia Biopharma
6:31am
8-K
nq6o4xuefs3ei3p0fdws
6 Aug 20
Principia Biopharma Reports Second Quarter 2020
4:17pm
8-K
e7mjp
26 Jun 20
Principia Announces First Patient Enrolled in Sanofi’s Phase 3 Trial of SAR442168 in Relapsing Multiple Sclerosis
4:05pm
8-K
2fvkbubda3 q3c
12 Jun 20
Principia Presents Updated Positive Data of Rilzabrutinib for Immune Thrombocytopenia in Ongoing Phase 1/2 Trial
6:10am
8-K
5nws o464if
9 Jun 20
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
glxu2pb 0n1v201d8j9c
6 May 20
Principia Biopharma Reports First Quarter 2020 Financial Results
4:15pm
DEFA14A
j5ut1up3pj66apo8
24 Apr 20
Additional proxy soliciting materials
4:18pm
8-K
wplen9o5p88sps74so
24 Apr 20
Other Events
4:05pm
S-8
k1o8czpk
10 Mar 20
Registration of securities for employees
5:02pm
8-K
tap dg2tesce
10 Mar 20
Principia Biopharma Reports Fourth Quarter and Full Year 2019 Financial Results
4:11pm
8-K
5ac 3u5nb
7 Feb 20
Other Events
12:00am
8-K
8ucpc50nfkg6eo9vl5vg
10 Jan 20
Principia Announces Expanded Development Program to Broaden BTK Footprint in Immune-Mediated Diseases
4:30pm
8-K
u66jne 2gf8iqxjne1pp
9 Dec 19
Principia Presents Consistent Positive Data of PRN1008
6:09am
8-K
svgd61x6
5 Nov 19
Principia Biopharma Reports Third Quarter Financial Results
4:10pm
8-K
7f0gsl9l6ig
18 Oct 19
Entry into a Material Definitive Agreement
4:14pm